Why glucose control matters

Persistently raised blood glucose can increase the risk of:

  • heart disease
  • stroke
  • kidney disease
  • nerve damage
  • vision problems

Treatment aims to reduce this long-term risk while minimising side effects and hypoglycaemia (low blood sugar).

Learn more: Diabetes and Endocrine Health

Main Classes of Diabetes Medicines

Metformin reduces glucose production in the liver and improves insulin sensitivity. It is commonly used as an initial treatment for type 2 diabetes unless contraindicated.

It is particularly helpful in people with insulin resistance and may support modest weight stability.

Monitoring may include:

  • kidney function
  • gastrointestinal tolerance
  • periodic HbA1c measurement

Common side effects include gastrointestinal discomfort, particularly when starting treatment.

SGLT2 inhibitors lower blood glucose by increasing glucose excretion in urine.

Common examples include dapagliflozin and empagliflozin.

These medicines are often considered in people who:

  • have type 2 diabetes
  • have cardiovascular disease
  • have chronic kidney disease
  • would benefit from weight reduction

They may also provide heart and kidney protective benefits in selected individuals.

Monitoring includes kidney function and awareness of dehydration or infection risk.

GLP-1 receptor agonists work by enhancing insulin release in response to food, slowing stomach emptying, and reducing appetite.

Common examples include semaglutide and dulaglutide.

They are often used in people who:

  • require additional glucose lowering
  • would benefit from weight reduction
  • have cardiovascular risk factors

They are typically injectable medicines, although some oral options exist.

Monitoring focuses on tolerance, gastrointestinal side effects, and overall metabolic response.

DPP-4 inhibitors enhance the body’s natural incretin hormones, supporting glucose-dependent insulin release.

Common examples include sitagliptin and linagliptin.

They are generally well tolerated and have a low risk of hypoglycaemia when used alone.

Sulfonylureas increase insulin release from the pancreas.

Common examples include gliclazide.

They can be effective but carry a higher risk of hypoglycaemia and weight gain compared with some newer medicines.

Monitoring includes blood glucose review and awareness of low blood sugar symptoms.

Insulin is essential for people with type 1 diabetes and may be required in type 2 diabetes when oral or injectable non-insulin therapies are insufficient.

There are different types of insulin, including:

  • rapid-acting
  • long-acting
  • mixed preparations

Insulin therapy requires structured education, glucose monitoring, and careful dose adjustment. In primary care, insulin management is often shared with specialist diabetes teams.

Hypoglycaemia (Low Blood Sugar)

Some diabetes medicines, particularly insulin and sulfonylureas, can cause low blood sugar.

Symptoms may include:

  • sweating
  • shaking
  • confusion
  • dizziness
  • fainting

Anyone experiencing recurrent or severe hypoglycaemia should seek medical review.

Low blood sugar (hypoglycaemia): what to do

A quick guide for patients and people supporting them. If someone is unconscious or having a seizure, call 999 immediately.

Step 1: Recognise symptoms Sweating, shaking, hunger, palpitations, confusion, irritability, dizziness, or blurred vision.
Step 2: Give fast-acting sugar If the person is awake and able to swallow, give a quick source of sugar (for example glucose tablets or a sugary drink).
Step 3: Recheck and repeat if needed Wait around 10 to 15 minutes and reassess. If symptoms persist, repeat the fast-acting sugar and seek advice if not improving.
Step 4: Follow with longer-acting food Once improved, take a longer-acting snack (for example a sandwich or biscuits) to help prevent the low from returning.

Call 999 urgently if the person is unconscious, cannot safely swallow, is having a seizure, or does not improve quickly. If prescribed emergency glucagon, follow their care plan and seek emergency help.

Monitoring and Long-Term Review

Diabetes medicines require structured monitoring, including:

  • HbA1c measurement
  • kidney function
  • blood pressure
  • weight
  • lipid profile
  • review of side effects

Medication regimens may change over time depending on response and co-existing conditions.

You can read more in:

Weight and Metabolic Health

Some diabetes medicines may support weight reduction, while others may contribute to weight gain.

Treatment decisions increasingly consider metabolic health as a whole, including:

  • weight
  • cardiovascular risk
  • kidney protection
  • blood pressure

Medication is usually part of a broader plan including nutrition, activity, and lifestyle measures.ed by symptom type, severity, and safety for work, driving, or pregnancy.

Diabetes Medicines in Remote GP Care

Many diabetes medication reviews can be conducted remotely, particularly when blood test results and home glucose readings are available.

However, symptoms of severe hyperglycaemia, hypoglycaemia, or acute illness may require urgent assessment.


1. What is the first medicine usually prescribed for type 2 diabetes?

Metformin is commonly used as an initial treatment for type 2 diabetes, unless there is a reason it is not suitable. However, treatment plans vary depending on individual health factors.

2. Can diabetes medicines help with weight loss?

Some medicines, such as certain GLP-1 receptor agonists and SGLT2 inhibitors, may support weight reduction. Others may not affect weight or may cause weight gain. Treatment choice depends on overall health goals and safety.

3. Do diabetes medicines need to be taken for life?

Many people require long-term treatment, but medication plans may change depending on blood glucose control, weight, lifestyle changes, and overall health.

Further Reading and Hub Links

Visit our Medication and Prescribing hub or browse more health topics in the AccessGP Knowledge Base.

If you are concerned about blood sugar control, medication side effects, or metabolic health, a GP can help guide you on the safest next step.

Last reviewed by Dr Zamiel Hussain, GMC registered GP
Updated: 11 February 2026